ArticleJMIR research protocols2026
Implementation and Evaluation of an AI-Assisted Telerehabilitation System for Postdischarge Continuation of Rehabilitative Care: Protocol for a Randomized Controlled Trial.
Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06683963 (AI-Assisted TelerehabiLitAtion System), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
AI-Assisted TelerehabiLitAtion System (ATLAS) for Post-discharge Continuation of Rehabilitative Care
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization (WHO) launched a Rehabilitation 2030 initiative to call for global action to scale up rehabilitation efforts. Rehabilitation needs are growing, and efforts should be made to strengthen and integrate rehabilitation into all levels of health care, including building research capacity and expanding evidence for rehabilitation. Postdischarge rehabilitation is essential for reducing hospital readmissions and maintaining patients' health within the community. However, locally, the shift toward community-based rehabilitation is often hampered by long waiting times for admission to day rehabilitation centers (DRCs), cost and logistical barriers, and the lack of a structured program to onboard patients and caregivers to the digital solutions required for rehabilitation in Singapore. Telerehabilitation systems that incorporate wearables within a structured rehabilitation program support inpatient rehabilitation and enable patients to continue with physical rehabilitation after discharge while awaiting admission to a DRC.
objectiveThe aim of this randomized controlled trial (RCT) is to investigate the clinical and cost-effectiveness of ATLAS, an AI-assisted telerehabilitation system, among patients admitted to community hospitals (CHs) for rehabilitation.
methodsThis is a 2-arm pragmatic RCT. Participants admitted to CHs for rehabilitation for hip fracture, musculoskeletal conditions, or deconditioning will be enrolled and randomized to either the intervention or control group in a 1:1 ratio. The intervention group, in addition to usual care, will be enrolled in an ATLAS system. The ATLAS system consists of Rebee, an AI-assisted device equipped with a lightweight wireless motion sensor that patients can strap on for real-time feedback and log their exercises via the Rebee application to an electronic platform, as well as a therapist-designed, structured exercise program that patients follow during their inpatient stay and continue upon discharge. The control group will continue to receive usual rehabilitative care in the CHs and upon discharge but will not have access to the ATLAS system. Our primary outcome is functional status. Secondary outcomes include quality of life, length of stay in the CH, 30-day readmission rates, and cost-effectiveness.
resultsA total of 407 participants were recruited between January and September 2025 across 3 CHs, with data collection completed in December 2025. Data analysis is currently underway, and the results are expected to be submitted for publication in Q4 2026.
conclusionsOur trial will provide valuable insights into the effectiveness and implementation of an AI-assisted telerehabilitation system for patients admitted to the CH for rehabilitation for hip fracture, musculoskeletal conditions, or deconditioning. This trial will also evaluate the sustainability and cost-effectiveness of the ATLAS system, with the potential of scaling across inpatient settings in both acute and CHs.
trial registrationClinicalTrials.gov NCT06683963; https://clinicaltrials.gov/study/NCT06683963. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/78400.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.